NCT06870890Not yet recruiting
Impact of Sarcopenia on Dyspnea in Patients With Asthma
Source: ClinicalTrials.gov · Last updated 11 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Dyspnea in asthma, is mainly due to airway obstruction but can be caused by several alternative diagnoses. The impact of sarcopenia on dyspnea in patients with asthma is unknown. Sarcopenic asthma had a reduced physical activity and is associated with airway obstruction compared to non-sarcopenic asthma. In patients with obstructive pulmonary disease, sarcopenia is associated with shallow breathing and diverse sensory and affective components of exertional dyspnea . The morbidity of sarcopenia is also increased by systemic inflammation and the production of inflammatory cytokines as found in inflammatory airway obstruction. The investigators will investigate the prevalence and impact of sarcopenia in asthmatics patients. This will enable to better manage sarcopenia in asthmatic patients, understand its origins and personalize treatment.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 24 Feb 2025
- Start date
- 25 Mar 2025
- Primary completion date
- Oct 2025
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Diseases
- Asthma
- NCT number
- NCT06870890
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 25 Mar 2025 to the primary completion date, Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unstable heart disease
Other
- Patient under guardianship/trusteeship/supervision of justice
- Pregnant or breast-feeding women
- Patients who have been smoking or have stopped smoking for less than 5 years,
Who the study is looking for
- Age ≥ 18 years
- Patient affiliated to a social security scheme.
- Patient capable of giving free, informed, written and signed consent.
- Asthmatic patients with a diagnosis made by a pulmonologist on GINA level 4 or 5 treatment
- ACT asthma control score \< 20
- Patient judged by the investigator to be able to to perform a maximal exercise test.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Clermont-Ferrand Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.